Science topic
Metabolic Diseases - Science topic
Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
Questions related to Metabolic Diseases
is there any link(s) between insulin resistance and ghrelin resistance?
To GDC2030@who.int
Respected, Sir/ Madam
I want to draw your attention towards the diabetes eradication program. Diabetes is a metabolic disorder and it is not correct by any Medicine, Substitute, Yoga or Exercise. If possible please tell me. In our body first diabetes1 comes and after some time it changes into diabetes 2 I request you and your team, Please read my book Your Health Is In Your Mouth English https://www.lulu.com/account/projects/zgvvk6
Hindi https://www.flipkart.com/aapka-swasth-aapke-muh-me/p/itm22edae101e74a?pid=9789393385543
I want your company
Looking forward to hearing from you soon.
1. Please explain Biochemical levels in biochemistry.
2.Relationship between genetic mutations and metabolic disorders.
Metabolic disorders occur due to our proper habits of eating process and remineralisation in the mouth. Like food, water, and liquids, etc. Due to mutations in all our food in saliva, the imbalance of minerals in our body parts and some parts of our body and endocardial gland malfunction. If we do not change our habits, then we will feel difficulties, and these habits, abnormalities, and things are going to our inborn children. And problems are increasing day by day. We are seeing that our inborn children suffer from metabolic disorders from birth, like diabetes, etc. These habits, abnormalities, and genes we cannot correct with any medicine, substitutes, or research like stem cells, gene therapy, etc. "Habits Is a Second Nature “I request all people. Please read my book and follow the eating rules. Then we can achieve victory over metabolic disorders. I welcome all of you at these links:- https://www.lulu.com/shop/innovator-pramod-stephen/your-health-is-in-your-mouth/paperback/product-zgvvk6.html?page=1&pageSize=4 https://www.flipkart.com/aapka-swasth-aapke-muh-me/p/itm22edae101e74a?pid=9789393385543
Universal question: - Can diabetes & metabolic disorders be cured by any medicine and substitute? For answer: - https://www.lulu.com/shop/innovator-pramod-stephen/your-health-is-in-your-mouth/paperback/product-zgvvk6.html?page=1&pageSize=4 सार्वभौमिक प्रश्न:- क्या मधुमेह और चयापचय संबंधी विकारों को किसी दवा और विकल्प से ठीक किया जा सकता है? उत्तर के लिए:-https://www.flipkart.com/aapka-swasth-aapke-muh-me/p/itm22edae101e74a?pid=9789393385543
Diabetes is most prevalent all over the world especially type-II diabetes. India is called the 'Diabetic Capital' as this metabolic disorder is most prevalent in our country Therefore, is there anything like signature medicine or advanced genetic engineering tool for type-II diabetes to have sigh of relief for the patients ?
Genetic diseases commonly observed in Pakistan include:
Thalassemia, Cystic Fibrosis, Congenital Heart Diseases, Neurological Disorders, Metabolic Disorders.
In your country, which genetic disease you observe most?
For correct metabolic disorder Please Read my Book " Your Health Is In Your Mouth " Published by lulu.com
Opinions on "Brain Energy, A Revolutionary Breakthrough in Understanding Mental Health and Improving Treatment for Anxiety, Depression, OCD, PTSD, and More" by Christopher M. Palmer, MD.
Is there any publication that contains this data?
Trying to make the most of my time staying at home in this pandemic. I will love you help with articles that give good overview on metabolism and metabolic diseases
Dear Bariatric Surgeons,
The importance of obesity management in patients with BMIs over 50 has not been completely addressed and it should be considered separately from patients with morbid obesity.
Despite standardized guidelines for reporting the outcomes of bariatric/metabolic surgery for patients with severe obesity, new insight into for specific situations such as in patients with BMIs over 50 is needed. In recent decades, there has been an increase in the number of patients with BMI>50 kg/m2 who present unique challenges for bariatric surgeons. Therefore, there is an unmet need to better define their weight loss outcomes. In addition, there is also a need to consider standardizing the surgical management of patients with BMIs over 50.
This survey, if filled out by a large number of bariatric surgeons, would provide important insight into the bariatric surgical procedures performed on patients with BMI>50 and also give insight into their perioperative care.
To the best of our knowledge this would be the first study on this important topic.
In this light we created this survey entitled "The First Survey Addressing Patients with BMIs over 50." We urge all IFSO members to please complete the survey. The information extracted from this survey may positively impact our care for patients with BMIs over 50.
The survey has 50 questions divided in 4 parts which is submitted via Survey Monkey at the link https://www.surveymonkey.com/r/7W9K9FK
The survey has been designed by 15 bariatric surgeons from around the world: Luciano Antozzi, Miguel Carbajo, Sonja Chiappetta, Amirhossein Davarpanah Jazi,
Radwan Kassir, Mohammad Kermansaravi, Panagiotis Lainas, Kamal Mahawar, Mario Musella, Chetan Parmar, Shahab Shahabi, Scott Shikora, Ramon Villalonga, Antonio Vitiello, Lorea Zubiaga.
We thank you in advance for your positive action!
Mohammad Kermansaravi
Mario Musella
Scott Shikora
Tay-Sachs disease is a metabolic disorder that is common in Ashkenazi Jewish. Infants with the disease might express deafness, blindness, and/or paralysis. These symptoms are due to loss of neurons as lipid is not metabolized properly which leads to its accumulation on the nerve cells, then subsequently their destructions. A nonsense mutation in HEXAgene lead to form a truncated hexosaminidase A enzyme that is not efficient for lipid metabolism.
1) What is the molecular technology to analyze the product of HEXA gene mutation? (2 marks)
2) Write the principle of this technique?
3) Explain the expected results of this technique if you compared a sample for a Tay-Sachs patient and a sample for a normal control.
Chronopharmacology is branch of biological science which deals with daily life, sleep and wake, day and night, feeding and fasting and other effects. we can manage many diseases including diabetes, obesity, and CVDs with help of circadian rhythms or clocks,
you can watch my recent video on chronopharmacology for all the information
They used data from a medical study, which included 1491 volunteers: 737 women and 754 men. All the inquiries were taken in accordance with the Declaration of Helsinki, at the Department of Endocrinology, Diabetes and Metabolic Disorders of the Clinical Centre of Vojvodina in Novi Sad (Serbia) during the morning hours (after overnight fasting).
I was reading about metabolic disorders caused by the lack of production of a protein. Can a possible treatment be to supplement the patient with that lacking protein, or would the body degrade it before it acts upon it?
Treating children known to have metabolic disorders often includes ensuring adequate amount of calories for age and weight to avoid catabolism, that is usually by giving glucose solution 10%.
What is the long term impact of the sugary fluids on these patients?
Does it contribute to generating some degree of insulin resistance?
Can we predict the insulin resistance if so?
will HOMA-IR serve as a good predictor test?
In most of the communities especially are owned by lower socioeconomic status.Diet contains more of carbohydrate than protein and fat. More carbohydrate after catabolism produce more saturated fatty acids. This may disturb the level of LDL( high ) lead to atherosclerosis.
microRNAs have been shown to have a role in prevention of cancer, however are there any articles on its roles in metabolic disease?
Gut microbiota play significant roles in human health. With the help of Next-gen sequencing, we know much about the compositions of bacteria in the gut but little is known about their activities. What is the default state of bacteria in the gut? Are most bacteria living in the gut at near stationary phase with basal metabolic activity? Do they become more active after a meal? Or they are always active? For example, what will a probiotic species do in the gut after they are taken by people? How many and how long will they colonize and grow in the gut?
NAFLD is currently the main cause of chronic liver disease in developed countries, and the number of NAFLD patients is growing worldwide. NAFLD often has similar symptoms to other metabolic disorders, including type 2 diabetes and obesity. Recently, the role of the gut microbiota in the pathophysiology of many diseases has been revealed. Regarding NAFLD, experiments using gut microbiota transplants to germ-free animal models showed that fatty liver disease development is determined by gut bacteria. Moreover, the perturbation of the composition of the gut microbiota has been observed in patients suffering from NAFLD. Numerous mechanisms relating the gut microbiome to NAFLD have been proposed, including the dysbiosis-induced dysregulation of gut endothelial barrier function that allows for the translocation of bacterial components and leads to hepatic inflammation.
I read this article :
Safari, Z. & Gérard, P. Cell. Mol. Life Sci. (2019) 76: 1541. https://doi.org/10.1007/s00018-019-03011-w
Sincerely Angel Carlos Bassols Ricardez, MD
I am collecting some data on BMI and looking at its relationship with diabetes/HTN or Dyslipidemia in our population. Given the present increase in obesity, there is always a question from the public, how likely will I get any of the above? I thought local data would be of some help in this regard.
First, have there been a research on repression of ChREBP-B gene expression and how would GLUT4 be affected?
Also, are there research on consequences or benefits of repression/expression of this particular gene?
Lastly, is this a mutated form of ChREBP-a and lead to metabolic diseases or a gene with necessary functions?
Hi all,
I am an undergrad in a physiology lab. I am investigated the role of ferulic acid on certain markers. My PI proposed an experiment involving the overnight loading of high ferulic acid esterase producing bacteria onto cell culture. I'm having trouble finding a similar type of protocol in literature. I was thinking of heat-killing the bacteria, since FA is not a protein so potential aggregation would not be a problem. I'm unsure if there is a better technique available and I am simply lacking the term for the technique to looking into. Any help would be greatly appreciated.
Thanks
Romina
Vitamin D is interlinked with metabolic diseases which causes obesity, diabetes, CVDs, immune disorders, gut microbionta issues in human if sufficient Vitamin D is not provided. so, multiple sources of vitamin D are superfoods, sun exposure, skin types and some other sources, so how can we get rid of metabolic diseases through Vitamin D supplementation, Please highlight issues related to vitamain D and metabolic diseases to tackle these diseases.
The role of hyperglycemia, saturated fatty acids, oxidative stress, inflammatory cytokines have been investigated in causing insulin resistance. However, is hyperinsulinemia itself not likely to cause insulin resistance as a negative feedback mechanism?
Thiazolidinedione (TZD) binds to nuclear transcriptional factor PPAR-gamma, thereby causing metabolic reprogramming. This drug for the treatment for insulin resistance in type-II DM has been modified into HA15, the novel compound leading ER stress by directly and specifically binding with BiP, also referred to as GFP78. This is the typical case of drug repositioning. Here, HA15 has been shown to promote the dissociation of the ER stress-related molecule complex composed of PERK, IRE1-alpha, and ATF4, therefore reducing the ATPase activity of BiP, which is responsible for the attenuated UPR potential. In addition to the fact that HA15 can overcome the therapeutic limitations against BRAF inhibitor-resistant melanoma cells, they do not at all affect the cellular viability of human normal fibroblasts or melanocytes. It is notable that they also harbor the similar ER stress machinery, but BiP in the normal cells does not seem to be disturbed. What is the difference of BiP (GRP78) between normal and malignant cells in the regulation of ER stress?? Si-RNA-mediated BiP depletion would be the useful experimental design?
According to common soil hypothesis metabolic diseases are associated with each other due to underlying insulin resistance.
What is your take on that?
Does anyone have any papers for the epidemiology of cardiometabolic disease in UK.
NOT cardiovascular disease.
Thanks.
While patients with metabolic ailments like hypertension, diabetes, heart disease and cholesterol issues are already taking so many prescription medicines.
If we have to recommend any fruit to them what could be our preferable choices and for what reasons?
Infectictous, metabolic, endokrinological, toxic, drug abuse, ect.
Dear esteemed colleagues,
Does anyone have any insight why most of the neuroendocrine studies, i.e hypothalamus-pituitary-peripheral organs axis, are mostly studied in mice? I do know some studies were done in rat, and even there are some rat animal models (HFD, genetic models, streptozocin, etc) but to my knowledge this is overwhelmingly minor compared to mouse models.
Is there any particular reason, such as mice neuroendocrine system more closely mimics human's? Or is there any technical reason? Thank you!
Multiple studies have recently highlighted association between vitamin D deficiency and metabolic disorders like hypercholessterolemia, diabetes, heart diseases and hypertension and others
Kindly have your say whether do you consider vitamin D deficiency as the main culprit behind these diseases or just an association implying a result following these diseases
Need you input please
How can we upgrade the peptide yy in diet and control our obesity and get benefits from it for diabetes and other metabolic diseases. its best way that natural path be chosen for these types of diseases. in addition in bariatric surgery there is no removal or blockage of peptide yy pathway, is this true. herbal drugs if any effective for peptide yy to push or stimulate. Ghreline is another hormone which is also effective for diet control.
Please go through these 3 references:
1. An excerpt from wikipedia: (https://en.wikipedia.org/wiki/Lipid) reads:
"A few studies have suggested that total dietary fat intake is linked to an increased risk of obesity (Astrup, 2005; Astrup et al., 2008) and diabetes (Astrup, 2008). However, a number of very large studies, including the Women's Health Initiative Dietary Modification Trial, an eight-year study of 49,000 women, the Nurses' Health Study and the Health Professionals Follow-up Study, revealed no such links (Beresford et al., 2006; Howard et al., 2006). None of these studies suggested any connection between percentage of calories from fat and risk of cancer, heart disease, or weight gain."
2. Watch the video, Sugar the bitter truth by Robert H. Lustig, MD, UCSF professor of pediatrics in the division of endocrinology (https://www.youtube.com/watch?v=dBnniua6-oM).
3. Read this book by John Yudkin: http://www.teethforlife.co.za/images/Pure,%20White%20and%20Deadly%20-%20%20John%20Yudkin.pdf
Analogy: So is it logical to exonerate sugar and indict fat cholesterol as the major causes of heart diseases, increase in blood pressure, obesity, type 2 diabetes etc?
Epigenetics is very important branch, what are major researches have done, what new inventions have indicated in the treatment of obesity and diabetes or metabolic disorders, gene therapy or other related information for the benefits of humans.
Losing body weight is one of the most searched topic on the net. Overweight and obesity become the root cause of majority of metabolic diseases and many kinds of cancer & other medical conditions.
A lady aged about 40 years has lost 23 kilograms (50.7 pounds) in a period of 6 months based on a dietitian diet.
Laboratory Animal models are very essential for measuring in-vitro and in-vivo test in animal models of diabetes and other diseases, alternative methods have launched like cell culture and spectroscopies and microscope levels. What are latest models including most commonly employed ones.
REFERENCES
1. Apelin and Sirtuin 1 Dysregulation induce Endocrine and Metabolic Disorders in Chronic Disease. 1(1). GJEM.000501. 2017.
2. The Future of Genomic Medicine Involves the Maintenance of Sirtuin 1 in Global Populations. Int J Mol Biol . 2017. 2(1): 00013.
Anecdotally, much of the healthcare provided to people living with severe mental illness focuses on their mental health, negating physical health concerns including chronic disease. The co-morbidity of metabolic diseases (diabetes) and COPD (smoking) is especially large in this cohort, but are generally not receiving Management Plans from their GP, or are not following up referrals.
How can we improve these outcomes?
I'd like to hear your thoughts and inputs :)
Homocystinuria is a metabolic error of the homocysteine, which can be caused by the deficiency of different enzymes. The most frequent is the deficiency of cystathionine β-synthase (CBS), also called classical homocystinuria. Because of this, amino acids are accumulated, like homocysteine and methionine, while others are deficient, like the cysteine. This last amino acid is a precursor of other important metabolic substances, like for example, glutathione, which is an important antioxidant and can be deficient in homocystinuria.
I wonder why impaired synthesis of GSH does not cause the oxidative stress-induced tissue damage?
Which organs or tissues CBS is expressed can explain the absence of the symptoms related to redox stress.
Is there a research niche that really needs a Cobas Fara analyser? What is it that other modern analysers miss? Would a modernised version be of interest or is it surpassed as a technology?
I am using Michigan Hand Questionnaire.
Let me know a manufacturer of copper-histidine API for a solution for treatment of Menkes
Hello,
Sorry for the English, it is basic.
I studied some recommendations of exercises for people with McArdle's disease, and found no reference to water aerobics activities (discarding swimming). They could give me a guidance?
thank you
I want to predict what Gram-ve intestinal flora would be interacting with host (human) genes, protein or transcription factors to cause or promote metabolic diseases. I know Toll like receptors involvement in DM2, Insulin resistance but its not the complete story. I want to predict this interaction using a computational approach to fulfill my idea.
Thanks if you have time to answer.
Hypophosphatemio is a verz dangerous metabolic situation by many patients, specillz in intenzive care unit, by status epilpticus, ect. It is necessery to proof the nvou of Phosphor, not only the standard electrolits. The correction must be very fast, because the start symptoms are unspecific, and the end can be paralysis of respiratorz muscels, coma and death.
Currently, bariatric & metabolic surgeons offer surgery for remission of DM in 'poorly controlled' T2DM patients. What exactly is 'poorly controlled' DM? Are there any guidelines?
Hi,
I was just wondering how tight junctions contribute to the development of diseases and if there is any known connection between Claudin 6 expression in developmental programming and/or the development of metabolic diseases?
Any thoughts/ comments?
Thanks,
Pooja.
It has been reported that in Niemann Pick disease Sphingosine accumulates in lysosomes and late endosomes. I attached one of the good studies regarding this disease.
However it is not clear why sphingosine levels will rise with the disease.
Niemann-Pick disease types A and B is caused by mutations in the SMPD1 gene. This gene provides instructions for producing an enzyme called acid sphingomyelinase. This enzyme is found in lysosomes, which are compartments within cells that break down and recycle different types of molecules. Acid sphingomyelinase is responsible for the conversion of a fat (lipid) called sphingomyelin into another type of lipid called ceramide. Mutations in SMPD1 lead to a shortage of acid sphingomyelinase, which results in reduced break down of sphingomyelin, causing this fat to accumulate in cells.
Sphingosine is producued through breakdown of ceramide by ceramidase.
Normally, one would expect decreased levels of Sphingosine following inhibition of ASM. Then why and how Sphingosine accumulates in Niemenn Pick disease?
I am validating a Transferrin saturation test in the order to replace the unsaturated iron binding capacity (UIBC) and am looking for any recent info comparing the two tests.
Does the geriatric population have widespread but unrecognized insufficiency of the adrenal cortex? Could this partly explain weight loss and depression in that age group?
I always have students calibrate the various components of our metabolic cart (e.g., mass air flow meter, O2 analyzer, CO2 analyzer). However, I am not sure what the total error of measurement is for final measurements such as VO2, VCO2, R, etc. I'd like to present a method to my students that would allow them to calculate the propagation of error for any complex measurement they might make in lab.
When studying some metabolic parameters in elderly people, it seems difficult to distinguish which ones are caused by aging per se or by age-related diseases. In particular, circulating IL-6 is known to increase with age but is it a relevant biomarker of aging since it is also elevated in metabolic diseases such as obesity or atherosclerosis. Then, is there a very specific biomarker of aging?
How can we characterize healthy elderly? For the recruitment of such cohort, do we exclude all kind of diseases or can we tolerate some?
We are looking at predicting adherence to medical and behavioral health care recommendations among individuals with metabolic syndrome. I'm curious if anyone might be able to provide personal insight into specific indicators (behavioral or otherwise) that have been effective/reliable in quantifying the construct of treatment adherence?
Overexpression of uncoupling proteins in small rodents is an effective way to alter thermogenesis. This strategy prevents diet induced obesity and insulin resistance (link 1). There is now substantial interest in alternative methods of increasing thermogenesis as a means to treat obesity (links 2 and 3). However, due to the volume : surface ratio, small rodents have a high tolerance for elevated thermogenesis (link 4) as a result of UCP overexpression. Humans have a much lower surface area : volume ratio and therefore have a reduced capacity to dissipate heat. Therefore, will overweight humans have a sufficient tolerance for enhanced thermogenesis for this to be a safe and viable treatment option?
I have induced type 2 diabetes mailitus using high fat diet (45% fat) plus multiple low dose of streptozotocin (30mg). So can any please tell me Which type insulin (Short, log, Intermidiate acting or Biphasic insuline) should be used to carry out Insulin Tolerance Test in type 2 diabetic rats?
Recent studies suggest that there is still a benefit without significantly increasing side effects, but I'm not convinced that long term or in certain subgroups of patients, the metabolic change that we generate with very aggressive treatment is safe.
Apart from the effects of dietary changes and variable therapeutic compliance,do you know if there are other sources of comorbidity (apart of diabetes, thyroid status and cholestasis) that may cause significant and temporary variation in the concentrations of major lipoproteins (without the pharmacological treatment) ?.
IL-18 is specific bio-marker of metabolic syndrome.
For free radicals activities directly affected in metabolic syndromes.
NAFLD shares many overlapping features with the insulin resistance syndrome, also known as "Syndrome X" including central or visceral obesity, type II diabetes, and dyslipidemia. Of course, NAFLD is now recognized as a hepatic manifestation of insulin resistance syndrome.
Several dedicated centers have published data regarding this, but our diabetology friends beg to differ. Any (unbiased!) thoughts?
Diabetes is a group of metabolic diseases in which a person has high blood sugar. This high blood sugar produces the symptoms of frequent urination, increased thirst, and increased hunger. Untreated, diabetes can cause many complications. Acute complications include diabetic ketoacidosis and nonketotic hyperosmolar coma. Serious long-term complications include heart disease, kidney failure, and damage to the eyes. Thus, I am looking for some new natural products to test them as anti-diabetic remedy in an animal model.
I used to follow ITO's method but I need something less time consuming? Any suggestions? Any other HPLC method more useful in routine analysis?
Does glutaric acid accumulate as a result of reduced carnitine availability? As a consequence of a lack of detoxification?
Metabolic syndrome includes several features that are amenable to short term trials. Hypertension due to stimulation of sodium resorption by insulin on the renal distal tubule responds quickly reducing insulin levels with very low sugar (carbohydrate) ketogenic diets (VLCKD). A trial of persons with hypertension would help to answer the question of whether primary hypertension is caused by this functional hyperinsulinemia. For midwives and obstetricians, the observation of hypertension and pre-eclampsia may indicate that a small trial would be worthwhile in women at relatively low risk for eclampsia.
While type 2 diabetes responds well to VLCKD's in randomized clinical trials, determining whether the reductions in inflammatory markers will either slow or stop progression of Alzheimer's type or inflammatory dementia are urgently needed and a proof of concept trial would not take a large number of subjects as the clinical course is generally progressive. Prevention of inflammatory dementias would take a much larger randomized trial but as dementia is a complication of type 2 diabetes and by association, metabolic syndrome, there may be a reasonable assumption of a positive trial. There is some evidence that this will be efficacious but in a non-definitive trial. Likewise the mood disorder associated with metabolic syndrome could be tested in a relatively small clinical trial.
As the adverse effects of VLCKD's are minimal, applications for the ethics approval for such clinical trials should not be difficult to obtain.
For clinicians wishing to carry out clinical trials in relatively small numbers of individuals as a precursor to obtaining funding and ethics approval for larger, more definitive trials, these trials are important clinically as the conditions are common and the trials feasible for the same reasons. Positive trials may affect the management of patients commonly seen in clinical practice through well funded larger randomized controlled trials.
.
We have a 9-old month infant with high level of blood Glycine. Urine for organic acids showed high levels of methyl malonic acid,, increased 3-OH-propionic acid & methyl citric acid. She has recurrent seizures, acidotic breathing and malnutrition. Her diet is Soya milk, boiled rice & vegetables.